MARATTO

article · IOSR Journal of Dental and Medical Sciences

Intracranial Hypertension Revealing Neuro-Behçet Disease With Favourable Outcome After Ventriculoperitoneal Shunt

2024Open accessMohamed I University

Abstract

A 39-year-old man had been diagnosed after rolling out all the other possible causes as having intracranial hypertension with bilateral papilledema secondary to Behçet’s disease with normal MRI scan. Despite treatment with steroids, methylprednisolone and repetitive LPs, he had little to no improvement. The patient later underwent a ventriculoperitoneal shunt operation with corticosteroid therapy and adjuvant treatment with topiramate and acetazolamide, which resulted in symptoms improvement. Thus, it is important to consider NBD in the differential diagnosis of patients with intracranial hypertension and bilateral papilledema and also ventriculoperitoneal shunting as an effective therapeutic alternative when medical treatment fail to normalize the intracranial hypertension building up

Research topics

  • Cerebral Venous Sinus Thrombosis
  • Ocular Diseases and Behçet’s Syndrome
  • Retinal and Optic Conditions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.9790/0853-2309053941

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.